Search Results - "OLAF PRIEN" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies

Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies

by Zurth, Christian, Koskinen, Mikko, Fricke, Robert, Prien, Olaf, Korjamo, Timo, Graudenz, Kristina, Denner, Karsten, Bairlein, Michaela, von Bühler, Clemens-Jeremias, Wilkinson, Gary, Gieschen, Hille
Published in European journal of drug metabolism and pharmacokinetics (01.12.2019)

Get full text

Journal Article

Target-Family-Oriented Focused Libraries for Kinases--Conceptual Design Aspects and Commercial Availability

Target-Family-Oriented Focused Libraries for Kinases--Conceptual Design Aspects and Commercial Availability

by Prien, Olaf
Published in Chembiochem : a European journal of chemical biology (01.03.2005)

Get full text

Journal Article

3,3‘-Dipyridyl BINOL Ligands. Synthesis and Application in Enantioselective Addition of Et2Zn to Aldehydes

3,3‘-Dipyridyl BINOL Ligands. Synthesis and Application in Enantioselective Addition of Et2Zn to Aldehydes

by Milburn, Robert R, Hussain, S. M. Shakil, Prien, Olaf, Ahmed, Zaheer, Snieckus, Victor
Published in Organic letters (25.10.2007)

Get full text

Journal Article

Characterization of the Pharmacokinetics of Vilaprisan: Bioavailability, Excretion, Biotransformation, and Drug–Drug Interaction Potential

Characterization of the Pharmacokinetics of Vilaprisan: Bioavailability, Excretion, Biotransformation, and Drug–Drug Interaction Potential

by Schultze-Mosgau, Marcus-Hillert, Höchel, Joachim, Prien, Olaf, Zimmermann, Torsten, Brooks, Ashley, Bush, Jim, Rottmann, Antje
Published in Clinical pharmacokinetics (01.08.2018)

Get full text

Journal Article

Drug-drug interaction (DDI) of darolutamide with cytochrome P450 (CYP) and P-glycoprotein (P-gp) substrates: Results from clinical and in vitro studies

Drug-drug interaction (DDI) of darolutamide with cytochrome P450 (CYP) and P-glycoprotein (P-gp) substrates: Results from clinical and in vitro studies

by Zurth, Christian, Graudenz, Kristina, Denner, Karsten, Korjamo, Timo, Fricke, Robert, Wilkinson, Gary, Seitz, Friedeborg, Prien, Olaf
Published in Journal of clinical oncology (01.03.2019)

Get full text

Journal Article

Evaluation of Clinically Relevant Drug–Drug Interactions and Population Pharmacokinetics of Darolutamide in Patients with Nonmetastatic Castration-Resistant Prostate Cancer: Results of Pre-Specified and Post Hoc Analyses of the Phase III ARAMIS Trial

Evaluation of Clinically Relevant Drug–Drug Interactions and Population Pharmacokinetics of Darolutamide in Patients with Nonmetastatic Castration-Resistant Prostate Cancer: Results of Pre-Specified and Post Hoc Analyses of the Phase III ARAMIS Trial

by Shore, Neal, Zurth, Christian, Fricke, Robert, Gieschen, Hille, Graudenz, Kristina, Koskinen, Mikko, Ploeger, Bart, Moss, Jonathan, Prien, Olaf, Borghesi, Gustavo, Petrenciuc, Oana, Tammela, Teuvo L., Kuss, Iris, Verholen, Frank, Smith, Matthew R., Fizazi, Karim
Published in Targeted oncology (01.10.2019)

Get full text

Journal Article

Absorption, distribution, metabolism and excretion of darolutamide (a novel non-steroidal androgen receptor antagonist) in rats

Absorption, distribution, metabolism and excretion of darolutamide (a novel non-steroidal androgen receptor antagonist) in rats

by Taavitsainen, Päivi, Gieschen, Hille, Korjamo, Timo, Kähkönen, Marja, Malmström, Chira, Prien, Olaf, Niehues, Michael, Sandmann, Steffen, Janssen, Wiebke, Koskinen, Mikko
Published in Xenobiotica (02.08.2020)

Get full text

Journal Article

Discovery and Characterization of BAY 1214784, an Orally Available Spiroindoline Derivative Acting as a Potent and Selective Antagonist of the Human Gonadotropin-Releasing Hormone Receptor as Proven in a First-In-Human Study in Postmenopausal Women

Discovery and Characterization of BAY 1214784, an Orally Available Spiroindoline Derivative Acting as a Potent and Selective Antagonist of the Human Gonadotropin-Releasing Hormone Receptor as Proven in a First-In-Human Study in Postmenopausal Women

by Panknin, Olaf, Wagenfeld, Andrea, Bone, Wilhelm, Bender, Eckhard, Nowak-Reppel, Katrin, Fernández-Montalván, Amaury E, Nubbemeyer, Reinhard, Bäurle, Stefan, Ring, Sven, Schmees, Norbert, Prien, Olaf, Schäfer, Martina, Friedrich, Christian, Zollner, Thomas M, Steinmeyer, Andreas, Mueller, Thomas, Langer, Gernot
Published in Journal of medicinal chemistry (22.10.2020)

Get full text

Journal Article

Metabolism and Mass Balance of the Novel Nonsteroidal Androgen Receptor Inhibitor Darolutamide in Humans

Metabolism and Mass Balance of the Novel Nonsteroidal Androgen Receptor Inhibitor Darolutamide in Humans

by Taavitsainen, Päivi, Prien, Olaf, Kähkönen, Marja, Niehues, Michael, Korjamo, Timo, Denner, Karsten, Nykänen, Pirjo, Vuorela, Annamari, Jungmann, Natalia A, von Bühler, Clemens-Jeremias, Koskinen, Mikko, Zurth, Christian, Gieschen, Hille
Published in Drug metabolism and disposition (01.06.2021)

Get full text

Journal Article

The Gatekeeper: Friend or Foe in Identifying the Next Generation of Kinase Inhibitors

The Gatekeeper: Friend or Foe in Identifying the Next Generation of Kinase Inhibitors

by Prien, Olaf
Published in ChemMedChem (01.11.2006)

Get full text

Journal Article

From the Insoluble Dye Indirubin towards Highly Active, Soluble CDK2-Inhibitors

From the Insoluble Dye Indirubin towards Highly Active, Soluble CDK2-Inhibitors

by Jautelat, Rolf, Brumby, Thomas, Schäfer, Martina, Briem, Hans, Eisenbrand, Gerhard, Schwahn, Stefan, Krüger, Martin, Lücking, Ulrich, Prien, Olaf, Siemeister, Gerhard
Published in Chembiochem : a European journal of chemical biology (01.03.2005)

Get full text

Journal Article

3,3‘-Dipyridyl BINOL Ligands. Synthesis and Application in Enantioselective Addition of Et 2 Zn to Aldehydes

3,3‘-Dipyridyl BINOL Ligands. Synthesis and Application in Enantioselective Addition of Et 2 Zn to Aldehydes

by Milburn, Robert R., Hussain, S. M. Shakil, Prien, Olaf, Ahmed, Zaheer, Snieckus, Victor
Published in Organic letters (01.10.2007)

Get full text

Journal Article

Simple synthesis of enantiomerically pure, protected cis-bicyclo[4.4.0]decane-1-carboxaldehyde derivatives from cyclohexanones by the 3-arenesulfonyloxazolidine route

Simple synthesis of enantiomerically pure, protected cis-bicyclo[4.4.0]decane-1-carboxaldehyde derivatives from cyclohexanones by the 3-arenesulfonyloxazolidine route

by Prien, O, Hoppe, D
Published in Synthesis (Stuttgart) (01.01.1996)

Get more information

Journal Article

COMPUESTOS DERIVADOS DE QUINOLINA, INHIBIDORES DE PROTEINA QUINASA; PROCESO DE PREPARACION; MEDICAMENTO; Y USO PARA TRATAR TRASTORNOS INVOLUCRADOS CON LA ANGIOGENESIS, LINFANGIOGENESIS O VASCULOGENESIS, TRASTORNOS DE LOS VASOS SANGUINEOS Y TRASTORNOS

COMPUESTOS DERIVADOS DE QUINOLINA, INHIBIDORES DE PROTEINA QUINASA; PROCESO DE PREPARACION; MEDICAMENTO; Y USO PARA TRATAR TRASTORNOS INVOLUCRADOS CON LA ANGIOGENESIS, LINFANGIOGENESIS O VASCULOGENESIS, TRASTORNOS DE LOS VASOS SANGUINEOS Y TRASTORNOS

by OLAF PRIEN, KNUT EIS
Year of Publication 01.02.2008

Get full text

Patent

OXO-SUBSTITUTED IMIDAZO[1,2B]PYRIDAZINES, THEIR PREPARATION AND USE AS PHARMACEUTICALS

OXO-SUBSTITUTED IMIDAZO[1,2B]PYRIDAZINES, THEIR PREPARATION AND USE AS PHARMACEUTICALS

by GUENTHER, JUDITH, BONIN VON, ARNE, EIS, KNUT, BADER, BENJAMIN, PRIEN, OLAF
Year of Publication 02.08.2016

Get full text

Patent

Life Saving Drugs. The Elusive Magic Bullet. By John Mann

Life Saving Drugs. The Elusive Magic Bullet. By John Mann

by Prien, Olaf
Published in Angewandte Chemie International Edition (21.10.2005)

Get full text

Book Review Journal Article

PYRAZOLOPYRIMIDINES AND SALTS THEREOF, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, METHODS OF PREPARING SAME AND USES OF SAME

PYRAZOLOPYRIMIDINES AND SALTS THEREOF, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, METHODS OF PREPARING SAME AND USES OF SAME

by INCE, STUART, SCHUCK, KARINA, HUSEMANN, MANFRED, LU, SHOUFU, PRIEN, OLAF, YU, HONGYI
Year of Publication 24.02.2015

Get full text

Patent

Substituted triazolopyridines

Substituted triazolopyridines

by Schirok Hartmut, Wengner Antje Margret, Siemeister Gerhard, Holton Simon, Prechtl Stefan, Briem Hans, Schulze Volker, Kosemund Dirk, Prien Olaf, Koppitz Marcus, Stöckigt Detlef, Lienau Philip, Bader Benjamin
Year of Publication 31.01.2017

Get full text

Patent

triazolopiridinas substituídas

triazolopiridinas substituídas

by DIRK KOSEMUND, ANTJE MARGRET WENGNER, VOLKER SCHULZE, MARCUS KOPPITZ, SIMON HOLTON, HANS BRIEM, STEFAN PRECHTL, DETLEF DÖCKIGT, PHILIP LIENAU, BENJAMIN BADER, OLAF PRIEN, GERHARD SIEMEISTER, HARTMUT SCHIROK
Year of Publication 08.11.2016

Get full text

Patent

OXO-SUBSTITUTED IMIDAZO[1,2B]PYRIDAZINES, THEIR PREPARATION AND USE AS PHARMACEUTICALS

OXO-SUBSTITUTED IMIDAZO[1,2B]PYRIDAZINES, THEIR PREPARATION AND USE AS PHARMACEUTICALS

by BADER BENJAMIN, GUENTHER JUDITH, EIS KNUT, PRIEN OLAF, VON BONIN ARNE
Year of Publication 15.05.2014

Get full text

Patent

1
2
3
4
5
6
7
8
9
10
11
Next
[15]